Judge Katsas Circuit Judge's Rulings on Interpretation Of Clinical Trial Data For Drug Efficacy

Explore Judge Katsas Circuit Judge's 1 rulings on interpretation of clinical trial data for drug efficacy. AI-powered summaries and legal analysis.

1
Cases
1
Mixed

Courts

cadc (1)

Judge Katsas Circuit Judge's Interpretation Of Clinical Trial Data For Drug Efficacy Opinions (1)

Vanda Pharmaceuticals, Inc. v. FDA

D.C. Circuit Reverses FDA's Rejection of Vanda's Hetlioz sNDA for Pediatric Use

D.C. Circuit · 2025-08-15 · Mixed · Impact: 65/100

Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a mixed outcome. The D.C. Circuit reviewed the FDA's refusal to approve Vanda Pharmaceuticals' supplemental ...

Frequently Asked Questions

Q: How many interpretation of clinical trial data for drug efficacy cases has Judge Katsas Circuit Judge decided?

CaseLawBrief tracks 1 interpretation of clinical trial data for drug efficacy cases decided by Judge Katsas Circuit Judge. The count updates as new opinions are published.

Q: What is Judge Katsas Circuit Judge's ruling pattern on interpretation of clinical trial data for drug efficacy cases?

Based on tracked cases, outcomes include: Mixed: 1.

Q: Which courts has Judge Katsas Circuit Judge served on for interpretation of clinical trial data for drug efficacy cases?

Judge Katsas Circuit Judge has decided interpretation of clinical trial data for drug efficacy cases in: cadc.

Explore More

All Judge Katsas Circuit Judge Cases All Interpretation Of Clinical Trial Data For Drug Efficacy Cases All Judges All Topics Search